Houston Methodist researchers have identified a key protein as a potential therapeutic target for stopping the body's immune ...

Hyderabad: IIIT Hyderabad, in collaboration with Nizam's Institute of Medical Sciences (NIMS), has released digitised ...

Enhancing clinical research in India with publicly accessible histopathological image datasets for cancer and kidney disease ...

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr ...

Hyderabad:IIIT Hyderabad (IIIT-H) and Nizam’s Institute of Medical Sciences (NIMS) have launched India’s first publicly ...

Atara Biotherapeutics (ATRA) announced that the FDA has placed a clinical hold on Atara’s active investigational new drug, or IND, ...

On Tuesday, the U.S. Food and Drug Administration (FDA) placed a clinical hold on Atara Biotherapeutics, Inc.’s (NASDAQ:ATRA) ...

Atara Biotherapeutics said the U.S. Food and Drug Administration placed a clinical hold on its active investigational new drug applications.

After receiving a complete response letter last week, the other shoe has dropped for Atara Biotherapeutics and its pipeline ...

PHILADELPHIA - Century Therapeutics, Inc. (NASDAQ: IPSC), a biotechnology firm with a market capitalization of $77.32 million ...